In general, the older AML cohort has a decreased prevalence of FLT3 mutations.44 While FLT3-ITD is generally considered a poor prognostic factor, the older cohort showed worse OS, both overall and in each of the four mutation subgroups. Here, FLT3 is linked to acute myeloid leukemia.